LEAF’s new website is up and running

I’m happy to announce that the Life Extension Advocacy Foundation, or LEAF, has launched their new website. Perhaps I should say ‘our new website’, as I have the privilege of being part of the team. Among the many resources available on the website, there’s a rich FAQ section, explaining the biology of ageing, the technologies we can use to defeat age-related diseases, and answers to objections to and concerns about rejuvenation. Check it out, and while you’re at it, have a look at our latest crowdfunding campaign for CellAge, currently 7% funded.

Crowdfunding against senescent cells on Lifespan.io

Today, Lifespan.io has launched a new crowdfunding campaign: CellAge: Targeting Senescent Cells With Synthetic Biology. As you may know, senescent cells are a major driver of a number of age-related diseases, and therefore a prime target for any respectable rejuvenation biotech platform. CellAge, a biotech company based in Edinburgh, aims to design synthetic promoters for safe and precise targeting of senescent cells, with the goal of developing senolytic gene therapies to remove them. Please, consider helping them with a donation—big or small, every dollar counts—and by spreading the word!

Ending Aging in Italian

As you might know, I’m Italian. I’ve long left Italy, so I won’t be able to attend the event which I’ll shortly tell you about, but I would still like to give it some extra visibility.

Ending Aging, the book by Aubrey de Grey describing how medical science will be able to fully treat ageing in the foreseeable future, has been translated into Italian with the title La fine dell’invecchiamento (literally, ‘the end of ageing’). The book was published by D Editore—an independent Italian publishing house foucused on transhumanism and related topics—and will be presented on December 1st, 2016, at 18:00 at the bookstore Libreria Cultora, located in via Ughelli 39, 00179 Rome, Italy.

If you’re Italian or speak Italian, you might want to attend. If you know any Italian or Italian speaker, you could help the rejuvenation cause by letting them know of this event. Probably, the most effective way of spreading the word is sharing the relevant Facebook event.

I’d like to thank Emmanuele Pilia for the efforts he put into this project. If you wish, you may follow him on Twitter and/or D Editore, both on Twitter and Facebook.

Thanks!

New fundraisers for SENS rejuvenation research

Hiya folks, just a quick note to let you know about two important things.

SENS 2016 winter fundraiser

Thanks to a generous grant from the Forever Healthy Foundation, every dollar donated to SENS until the end of this year will be doubled, up to the first 150.000$. (As a side note, FHF has already pledged 10$ million to SENS and SENS related research. These guys are awesome.)

FightAging!’s new fundraiser

In order to encourage regular donations to SENS, Reason of FA! and Josh Triplett have put together a matching fund of 24.000$ dollars; for a year starting on November 1st, 2016 they will match the donations of anyone signing up as a SENS patron.

fa-2016-fundraiser-2-600x400

Make a difference—help SENS bringing ageing under medical control!

Surprise! OncoSENS continues

The exciting announcement regarding the OncoSENS campaign I was talking about a few posts ago is that it got a 31-day extension, plus a matching fund of 15.000$. In other words, every dollar donated in the next 31 days will unlock an extra dollar from the fund, up to the first 15.000$. Right now the campaign is 58% funded, so there’s plenty of time to reach the goal and beyond. Pretty cool, eh? We’re counting on your help.

Short update

As I was saying elsewhere, the past month or so has been rather busy, and I haven’t had time to write a line anywhere. Now that that’s dealt with, let me give you a short update on what’s new with the rejuvenation world before I move on to some more meaty post.

You probably already know about Michael Greve’s lavish donation to ageing research, for which humanity as a whole should be grateful. That’s very good news. Still on the subject of money, the OncoSENS crowfunding campaign will end in about a day, and last time I checked it had reached around 56% of its 60.000$ goal. You still have time to make your contribution—they’re all welcome, big and small ones alike. I hear from Keith Comito of Lifespan.io that an “exciting announcement” about the campaign will be made during the RB2016 live streaming—because yes, they’re doing streaming it this year—and I’m looking forward to know what it is.

Cha-ching!

I’m a slow poster, you know that. Sometimes I’ve posted about ‘news’ that were a month old. That’s because life comes often in between.

However, this time around life can stuff it. I don’t want to be late for this news.

On July 12, 2016, SENS Research Foundation announced that Internet entrepreneur Michael Greve, who runs the Forever Healthy Foundation and KIZOO Technology Ventures, has committed a whopping 10.000.000$ (let me spell that for you: ten fucking million dollars) to SENS research and to startups focused on bringing rejuvenation therapies to the market.

In the words of Greve himself, “My goal is to provide support for the critical research of the SENS Research Foundation and to facilitate the development of the rejuvenation biotech industry and ecosystem. I think we should have more people contribute to the step-by-step creation of cures for the root causes of all age-related diseases. And we should have a whole rejuvenation industry based on the SENS treatment model including the self-accelerating feedback-loop of success stories and amazing opportunities for scientist [sic], entrepreneurs and VC investors. This will truly accelerate both research and therapies. I have decided to lead by example and make this $10 million commitment.”

Five of the 10 millions will be donated directly to SENS over the course of the next five years, while the other five, as said, will be donated to other startups of the field. The 5mln to SENS constitute 10% of the goal of SENS’s new initiative Project|21, meant to make the first human trials of rejuvenation biotechnologies happen by 2021.

That’s the kind of news that make my day. It’s the kind of news that makes you think rejuvenation biotechnologies just got a lot closer to being a reality.

However, don’t think that our job as rejuvenation supporters is over: We still need to keep spreading the word and donating what we can. Speaking of which, Lifespan.io’s OncoSENS campaign has been feeling terribly lonely as of late. It has reached a mere 19% of the goal, much less than other campaigns have reached in the same timespan. Why don’t you pay it a visit and bring in some friends?